Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites
ABSTRACT
High-risk human papillomaviruses (HPVs) immortalize keratinocytes by disrupting the retinoblastoma protein (Rb)/p16 pathway and activating telomerase. The E7 oncoprotein targets Rb, while the E6 oncoprotein induces telomerase activity in human keratinocytes. This study has examined the mechanism by which E6 activates telomerase. Expression of human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, was found to be increased in keratinocytes stably expressing HPV type 16 E6, suggesting that E6 acts to increase hTERT transcription. hTERT expression and telomerase activity were activated to significantly higher levels in cells expressing both E6 and E7 than in cells expressing E6 alone. This indicates that E7 may augment E6-mediated activation of hTERT transcription. In transient-transfection assays using hTERT reporters, the induction of hTERT expression by E6 was found to be mediated by a 258-bp fragment of the hTERT promoter, proximal to the ATG initiation codon. Previous studies have demonstrated that overexpression of Myc can activate hTERT expression, suggesting that Myc may be a mediator of E6-mediated hTERT induction. However, in cells stably expressing E6, no strict correlation between the level of Myc and the activation of hTERT was found. Consistent with this observation, mutation of the two Myc binding sites in the hTERT promoter only modestly reduced responsiveness to E6 in transient reporter assays. This indicates that activation of Myc-dependent transcription is not essential for E6-mediated upregulation of hTERT expression. The hTERT promoter also contains five GC-rich elements that can bind Sp1. Mutation of these sites within the 258-bp fragment partially reduced hTERT induction by E6. However, when mutations in the Sp1 sites were combined with the mutated Myc binding sites, all activation by E6 was lost. This indicates that it is the combinatorial binding of factors to Myc and Sp1 cis elements that is responsible for hTERT induction by E6.
Top-30
Journals
2
4
6
8
10
12
14
16
18
20
|
|
Journal of Virology
19 publications, 10.05%
|
|
Virology
10 publications, 5.29%
|
|
Viruses
7 publications, 3.7%
|
|
Cancers
5 publications, 2.65%
|
|
Oncogene
5 publications, 2.65%
|
|
Biochemical and Biophysical Research Communications
4 publications, 2.12%
|
|
Journal of Biological Chemistry
3 publications, 1.59%
|
|
PLoS ONE
3 publications, 1.59%
|
|
Journal of Medical Virology
3 publications, 1.59%
|
|
Experimental Cell Research
2 publications, 1.06%
|
|
American Journal of Pathology
2 publications, 1.06%
|
|
Mechanisms of Ageing and Development
2 publications, 1.06%
|
|
Gynecologic Oncology
2 publications, 1.06%
|
|
Journal of General Virology
2 publications, 1.06%
|
|
International Journal of Molecular Sciences
2 publications, 1.06%
|
|
Cells
2 publications, 1.06%
|
|
Frontiers in Oncology
2 publications, 1.06%
|
|
Nature Reviews Cancer
2 publications, 1.06%
|
|
Tumor Biology
2 publications, 1.06%
|
|
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
2 publications, 1.06%
|
|
Seminars in Oncology
2 publications, 1.06%
|
|
Tumour Virus Research
2 publications, 1.06%
|
|
Oral Oncology
2 publications, 1.06%
|
|
Diagnostic Cytopathology
2 publications, 1.06%
|
|
FEBS Letters
2 publications, 1.06%
|
|
Reviews in Medical Virology
2 publications, 1.06%
|
|
International Journal of Cancer
2 publications, 1.06%
|
|
Molecular and Cellular Biology
2 publications, 1.06%
|
|
Methods in Molecular Biology
2 publications, 1.06%
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
5
10
15
20
25
30
35
40
45
|
|
Elsevier
45 publications, 23.81%
|
|
American Society for Microbiology
24 publications, 12.7%
|
|
Springer Nature
23 publications, 12.17%
|
|
MDPI
20 publications, 10.58%
|
|
Wiley
17 publications, 8.99%
|
|
Taylor & Francis
4 publications, 2.12%
|
|
Frontiers Media S.A.
4 publications, 2.12%
|
|
Public Library of Science (PLoS)
4 publications, 2.12%
|
|
Bentham Science Publishers Ltd.
3 publications, 1.59%
|
|
American Society for Biochemistry and Molecular Biology
3 publications, 1.59%
|
|
SAGE
3 publications, 1.59%
|
|
Oxford University Press
3 publications, 1.59%
|
|
Cold Spring Harbor Laboratory
3 publications, 1.59%
|
|
Microbiology Society
2 publications, 1.06%
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.06%
|
|
Walter de Gruyter
2 publications, 1.06%
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 1.06%
|
|
IntechOpen
2 publications, 1.06%
|
|
S. Karger AG
2 publications, 1.06%
|
|
American Thoracic Society
1 publication, 0.53%
|
|
Canadian Science Publishing
1 publication, 0.53%
|
|
Impact Journals
1 publication, 0.53%
|
|
American Chemical Society (ACS)
1 publication, 0.53%
|
|
Maney Publishing
1 publication, 0.53%
|
|
Hindawi Limited
1 publication, 0.53%
|
|
American Association for Cancer Research (AACR)
1 publication, 0.53%
|
|
American Society of Hematology
1 publication, 0.53%
|
|
Annual Reviews
1 publication, 0.53%
|
|
BMJ
1 publication, 0.53%
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.